New cell implant aims to free type 1 diabetes patients from severe lows
NCT ID NCT06651515
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 23 times
Summary
This study tests a new treatment called SR-02, which uses insulin-making cells implanted in the abdomen (omentum) of adults with type 1 diabetes who have dangerous low blood sugar episodes. The goal is to see if the implant is safe and can help the body produce its own insulin again. Participants will need to take lifelong immunosuppressive drugs to prevent rejection of the implanted cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UPMC Presbyterian Shadyside
Pittsburgh, Pennsylvania, 15213, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.